Hemostemix (CVE:HEM) Trading Down 22.9% – Should You Sell?
Hemostemix Inc. (CVE:HEM – Get Free Report) shares fell 22.9% on Friday . The stock traded as low as C$0.18 and last traded at C$0.19. 504,239 shares traded hands during mid-day trading, a decline of 5% from the average session volume of 530,580 shares. The stock had previously closed at C$0.24. Hemostemix Stock Up 5.4 […]
More Stories
Pumpkin Power: Boost Immunity, Regulate Blood Sugar, and Protect Eye Health
By Ellen Wan Pumpkin is rich in functional ingredients and nutrients and offers many potential health benefits. Both scientific research...
GAMMA Investing LLC Raises Position in Eaton Corporation, PLC (NYSE:ETN)
GAMMA Investing LLC raised its position in Eaton Corporation, PLC (NYSE:ETN – Free Report) by 0.7% during the 1st quarter,...
Bristol Myers Squibb Company (NYSE:BMY) Shares Sold by Spire Wealth Management
Spire Wealth Management reduced its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 1.6% in...
Golden State Wealth Management LLC Acquires 974 Shares of Zoetis Inc. (NYSE:ZTS)
Golden State Wealth Management LLC increased its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 90.6% in the first...
Zoetis Inc. (NYSE:ZTS) Shares Sold by Bessemer Group Inc.
Bessemer Group Inc. decreased its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 42.6% during the 1st...
Golden State Wealth Management LLC Acquires 4,508 Shares of CSX Corporation (NASDAQ:CSX)
Golden State Wealth Management LLC increased its holdings in shares of CSX Corporation (NASDAQ:CSX – Free Report) by 123.1% in...